AEK-7511982-4/10002/1

Astrazeneca — FEI 3003363346

Refusal Details

Date
September 5, 2025
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
62IDL81 GOSERELIN ACETATE (ANTI-NEOPLASTIC)
Charges
75